MK-677 (Ibutamoren): What People Actually Pay

Why MK-677 Pricing Is Unusual

MK-677 has no FDA approval, no NDA holder, and no wholesale acquisition cost (WAC) listed in standard drug pricing databases. That makes it fundamentally different from every branded or generic medication with a retail pharmacy price 1. The compound was originally developed by Merck Research Laboratories in the 1990s, studied in clinical trials for growth hormone deficiency and sarcopenia, but never brought to market as an approved therapeutic 2.

Where People Buy It

Users acquire ibutamoren through three main channels: research chemical vendors (the most common and least regulated), compounding pharmacies that operate under state pharmacy board oversight, and telehealth peptide clinics that pair prescriptions with compounding fulfillment. Each channel carries a different price point and a different risk profile.

Why Prices Vary So Much

Research chemical vendors typically sell 30-day supplies of MK-677 capsules (25 mg each) for $40 to $70. Compounding pharmacies charge $60 to $120 for the same quantity, reflecting the cost of USP-grade ingredients and pharmacist oversight. Telehealth clinics bundle consultation fees on top of compounding costs, pushing monthly totals to $90 to $150. The FDA has issued warning letters to companies marketing unapproved GH secretagogues with drug claims 3.

The absence of FDA approval means no insurance plan, whether commercial, Medicare, or Medicaid, covers ibutamoren. Every dollar is out-of-pocket. This cost structure attracts price-sensitive buyers to the research chemical market, where product verification is weakest.

What the Clinical Evidence Actually Shows

Before examining user reviews, the clinical trial data provides a baseline for what ibutamoren does and does not do. Murphy et al. Conducted the longest published MK-677 trial: a 2-year, placebo-controlled study in 65 healthy older adults (ages 60 to 81). Oral ibutamoren 25 mg daily restored GH and IGF-1 pulsatility to young-adult levels without altering cortisol or prolactin 1.

GH and IGF-1 Effects

In that trial, mean IGF-1 levels increased by approximately 40% from baseline and remained elevated through month 24. GH pulse amplitude roughly doubled. These are measurable endocrine changes, not placebo effects 1. An earlier dose-finding study by Copinschi et al. Demonstrated that even a single 5 mg dose of MK-677 increased nocturnal GH release by 70% in young healthy men 4.

Body Composition Outcomes

Fat-free mass increased by 1.1 kg over 12 months in the Murphy trial, but the gain did not reach statistical significance at the 2-year mark 1. Nass et al. Studied MK-677 at 25 mg daily for 1 year in 66 older adults and found a significant increase in GH and IGF-1 but no improvement in functional measures or body composition beyond fat-free mass gains 5. The disconnect between endocrine markers and functional outcomes is the core reason ibutamoren never progressed to approval.

Side Effect Profile in Trials

The most consistently reported adverse effects in clinical studies include increased appetite, transient edema (especially in the first 2 to 4 weeks), and mild elevations in fasting glucose. Murphy et al. Noted fasting glucose rose by approximately 0.3 mmol/L at 2 months 1. Chapman et al. Confirmed appetite stimulation as a dose-dependent effect in obese subjects receiving MK-677 at 25 mg daily for 8 weeks 6. The Endocrine Society's 2019 clinical practice guideline on GH use in adults does not endorse oral GH secretagogues for any indication due to insufficient efficacy data 7.

What Reddit and Forum Users Report Paying

Online communities provide the most granular (and most biased) pricing data available. A recurring theme across r/peptides, r/sarmssourcetalk, and related subreddits is that MK-677 is considered "cheap" relative to injectable GH secretagogues like CJC-1295/Ipamorelin combinations.

Research Vendor Pricing

Frequently cited price ranges from 2023 to 2025 Reddit threads cluster around $45 to $65 for a 30-count bottle of 25 mg capsules. Liquid formulations (sold as "research solutions" with measured droppers) run slightly cheaper, $35 to $55 for a 30-day supply. Users consistently warn that the cheapest vendors often skip third-party certificate of analysis (COA) testing. GH and IGF-1 are the biomarkers users rely on to verify product legitimacy, and the standard recommendation in these forums is to draw IGF-1 labs at baseline and at 4 weeks 8.

Compounding Pharmacy Pricing

Users who obtain ibutamoren through a licensed compounding pharmacy, typically with a telehealth prescription, report costs of $80 to $120 per month for 25 mg capsules. This route provides USP-grade sourcing but adds prescriber consultation fees ($50 to $150 for initial visits). Several forum users describe switching from research vendors to compounding pharmacies after receiving products that failed to raise IGF-1 levels on bloodwork. The FDA's guidance on compounding pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act applies to these preparations 9.

Telehealth Clinic Bundles

Peptide-focused telehealth clinics bundle ibutamoren with other compounds (commonly CJC-1295, BPC-157, or sermorelin). Monthly packages range from $150 to $350, with MK-677 as one component. Isolating the per-compound cost is difficult in these bundles. Users in r/peptides report that standalone MK-677 prescriptions from telehealth providers average $90 to $130 monthly after initial consultation fees.

User-Reported Results and Satisfaction

Online reviews of MK-677 skew toward two distinct camps: users who report significant subjective improvements in sleep quality and recovery, and users who report primarily appetite increase and water retention with minimal visible body composition change.

Positive Themes

The most consistent positive report is improved sleep quality. Deep sleep is expected to improve with GH pulsatility restoration. Brandenberger et al. Demonstrated that GH secretion is tightly coupled to slow-wave sleep in healthy adults 10. Forum users frequently describe "the best sleep of my life" in the first 2 to 4 weeks, followed by adaptation. Several Reddit users report 10 to 20 ng/mL increases in IGF-1 from pre-treatment baselines, consistent with the 40% elevation seen in Murphy et al. 1.

Recovery from training is the second most common positive report. Users describe reduced muscle soreness and faster return to baseline performance between training sessions. However, GH's direct effect on skeletal muscle hypertrophy in eugonadal adults is limited according to a systematic review by Liu et al. That pooled 27 studies of GH administration 11.

Negative Themes

Appetite increase is the most frequently cited downside. Users attempting to use MK-677 during caloric restriction describe it as "counterproductive" because hunger becomes difficult to manage, particularly in the first 4 to 6 weeks. Chapman et al. Confirmed that ibutamoren increases 24-hour caloric intake by approximately 500 kcal in the first week of dosing 6.

Water retention and bloating appear in roughly one-third of user reports. Peripheral edema, particularly in the hands and feet, mirrors the trial data from Murphy et al. 1. Some users report numbness or tingling in the hands consistent with carpal tunnel symptoms, a known effect of elevated GH/IGF-1 levels documented by Svensson et al. In their study of GH secretagogues 12.

Satisfaction Versus Expectation Mismatch

A pattern emerges in longer-form reviews (Drugs.com, Trustpilot, and dedicated peptide forums): users who expected visible muscle growth comparable to anabolic steroids report disappointment. Users who expected better sleep, modest recovery improvements, and confirmed IGF-1 elevation on bloodwork report satisfaction. This expectation gap is consistent with the clinical evidence. GH secretagogues raise GH and IGF-1 reliably but do not produce the nitrogen-retention effects of exogenous testosterone or anabolic agents 13.

Sample Size and Selection Bias Warnings

Every online review dataset suffers from self-selection. People who experience dramatic effects (positive or negative) are more likely to post. The total published clinical trial population for MK-677 across all studies is fewer than 500 subjects 1 5 6.

Forum Data Limitations

Reddit and forum reports carry additional confounders. Users frequently stack MK-677 with other compounds (testosterone, SARMs, or other peptides), making it impossible to attribute effects to ibutamoren alone. Dosing accuracy from research vendors is unverified. And the demographics of online peptide communities skew heavily toward men aged 20 to 40, a population not well-represented in the published trials, which focused on adults over 60.

What Verified Reviews Show

Drugs.com hosts a small number of user reviews for ibutamoren (under 50 as of early 2026). Average ratings cluster around 6 to 7 out of 10. The most common reason for a low rating is appetite-related weight gain. The most common reason for a high rating is sleep improvement. This mirrors a well-established relationship between GH pulsatility and sleep architecture documented by Van Cauter et al. 14.

Cost Compared to Alternatives

Users considering MK-677 often compare it to injectable GH secretagogues, recombinant human GH (rhGH), and other oral compounds.

Versus Injectable GH Secretagogues

CJC-1295/Ipamorelin combinations through compounding pharmacies typically cost $150 to $300 per month. Sermorelin runs $100 to $250 monthly. MK-677's oral administration eliminates injection supplies and the inconvenience factor, which users cite as a primary reason for choosing it despite weaker clinical evidence. Tesamorelin, the only FDA-approved GHRH analog (for HIV-associated lipodystrophy), costs over $1,000 per month at retail 15.

Versus Recombinant Human GH

Pharmaceutical rhGH (Genotropin, Norditropin, Humatrope) costs $800 to $2,500 per month depending on dose and source. Underground-market GH runs $200 to $500 monthly with significant quality concerns. MK-677 at $40 to $120 per month represents a fraction of these costs, which explains its popularity despite the lack of FDA approval. The Endocrine Society recommends against GH use for anti-aging purposes in adults without documented GH deficiency 7.

The Hidden Cost: Monitoring

Responsible use of any GH-elevating compound requires baseline and follow-up labs. A comprehensive panel (IGF-1, fasting glucose, HbA1c, fasting insulin, complete metabolic panel) costs $100 to $300 per draw without insurance coverage. Users who test every 3 months add $400 to $1,200 annually to their total cost. Fasting glucose monitoring is particularly important given the insulin resistance signal in the Murphy et al. Data, where glucose elevations persisted throughout the 2-year trial period 1.

Safety Signals Worth Knowing Before Purchasing

Cost discussions cannot be separated from risk. MK-677 is not a benign supplement.

Glucose and Insulin Effects

The consistent fasting glucose elevation across trials raises concern for pre-diabetic or insulin-resistant individuals. Nass et al. Reported that fasting glucose increased by an average of 0.5 mmol/L over 12 months, with two subjects developing overt diabetes during the study 5. The American Diabetes Association's Standards of Care note that any agent raising fasting glucose warrants HbA1c monitoring at minimum every 6 months 16.

Regulatory Risk

The FDA has taken enforcement actions against companies selling unapproved GH secretagogues. In 2019, the agency issued warning letters to multiple vendors marketing products containing MK-677 with therapeutic claims 3. Purchasing from vendors who make explicit health claims increases the buyer's regulatory and quality risk. The FDA's BeSafeRx program provides resources for identifying illegitimate online pharmacies 17.

Product Authenticity Concerns

Third-party testing of research chemical products has revealed significant quality issues. Without FDA manufacturing oversight (cGMP enforcement), capsule content can vary by 20% or more from label claims. Users who verify their product via IGF-1 bloodwork provide the most reliable real-world efficacy signal, but this adds cost and complexity. The United States Pharmacopeia (USP) provides standards for compounded preparations that licensed pharmacies must follow 18.